Table 2.
Time | Ferritin (ng/mL) | SI (umol/L) | TIBC (umol/L) | UIBC (umol/L) | TS (%) | STfR (mg/L) | Hepcidin (ng/L) |
---|---|---|---|---|---|---|---|
Baseline (M0) | 72.96 ± 14.16 | 15.72 ± 6.21 | 56.70 ± 10.83 | 41.49 ± 14.00 | 27.85 ± 12.20 | 38.46 ± 7.75 | 116.12 ± 17.46 |
M1 | 65.69 ± 12.00 | 16.63 ± 7.64 | 54.59 ± 8.65 | 37.97 ± 12.35 | 31.62 ± 15.82 | 41.63 ± 7.57 | 86.72 ± 16.97 |
M3 | 55.54 ± 13.73 | 15.47 ± 5.23 | 48.93 ± 12.97 | 33.46 ± 13.92 | 33.58 ± 14.99 | 50.18 ± 7.73 | 78.86 ± 15.90 |
F value | 10.73 | 0.489 | 5.906 | 3.721 | 1.582 | 18.68 | 1034.523 |
P value | < 0.001 | 0.602 | 0.005 | 0.032 | 0.218 | < 0.001 | < 0.001 |
M0: before roxadustat; M1: 1 month after initiation of roxadustat; M3: 3 months after initiation of roxadustat (end of study)